Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways

Geraint B. Rogers

Source: Eur Respir J, 50 (5) 1701935; 10.1183/13993003.01935-2017
Journal Issue: November
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Geraint B. Rogers. Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways. Eur Respir J, 50 (5) 1701935; 10.1183/13993003.01935-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014



Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020


Stratified medicine: drugs meet genetics
Source: Eur Respir Rev 2013; 22: 53-57
Year: 2013



Practical microbiology of cystic fibrosis lung disease
Source: School Course 2013 - Cystic Fibrosis
Year: 2013

Airway microbiota across age and disease spectrum in cystic fibrosis
Source: Eur Respir J, 50 (5) 1700832; 10.1183/13993003.00832-2017
Year: 2017



Cystic fibrosis: coming of age
Source: Annual Congress 2010 - Paediatric Year in Review
Year: 2010


Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005

Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies
Source: Eur Respir J 2017; 49(1): 1600903; DOI: 10.1183/13993003.00903-2016
Year: 2017



The pathogenesis of pulmonary fibrosis: a moving target
Source: Eur Respir J 2013; 41: 1207-1218
Year: 2013



Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017

Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Small airways disease in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=21
Year: 2006

Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


New insights into the pathophysiology of lung disease in cystic fibrosis patients
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1
Year: 2006

Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014



Two-compartment model of gas mixing in patients with asthma and cystic fibrosis
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013

Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012